SCM
Silverarc Capital Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-19,940
| Closed | -$3.87M | – | 65 |
|
2024
Q3 | $3.87M | Buy |
19,940
+575
| +3% | +$111K | 0.87% | 36 |
|
2024
Q2 | $4.49M | Hold |
19,365
| – | – | 1.06% | 31 |
|
2024
Q1 | $4.18M | Sell |
19,365
-635
| -3% | -$137K | 1.16% | 29 |
|
2023
Q4 | $5.18M | Sell |
20,000
-8,069
| -29% | -$2.09M | 1.54% | 26 |
|
2023
Q3 | $7.21M | Buy |
28,069
+1,215
| +5% | +$312K | 2.19% | 10 |
|
2023
Q2 | $7.65M | Buy |
26,854
+15,543
| +137% | +$4.43M | 2.37% | 10 |
|
2023
Q1 | $3.14M | Sell |
11,311
-10,664
| -49% | -$2.96M | 1.3% | 26 |
|
2022
Q4 | $6.09M | Buy |
+21,975
| New | +$6.09M | 1.74% | 15 |
|
2022
Q3 | – | Sell |
-20,825
| Closed | -$4.25M | – | 73 |
|
2022
Q2 | $4.25M | Buy |
20,825
+10,577
| +103% | +$2.16M | 1.31% | 16 |
|
2022
Q1 | $230 | Buy |
10,248
+4,504
| +78% | +$101 | 0.1% | 58 |
|
2021
Q4 | $1.38M | Buy |
5,744
+1,355
| +31% | +$325K | 0.56% | 47 |
|
2021
Q3 | $1.24M | Buy |
+4,389
| New | +$1.24M | 0.7% | 46 |
|
2021
Q2 | – | Sell |
-5,000
| Closed | -$1.4M | – | 95 |
|
2021
Q1 | $1.4M | Buy |
5,000
+2,000
| +67% | +$560K | 0.76% | 46 |
|
2020
Q4 | $735K | Buy |
+3,000
| New | +$735K | 0.43% | 57 |
|